CANADA’S LARGEST NATIONAL DEMENTIA RESEARCH INITIATIVE INTRODUCES DEMENTIA PREVENTION PROGRAM
Canada’s largest dementia research initiative, the Canadian Consortium on Neurodegeneration in Aging (CCNA), has launched an innovative online program that offers older adults the opportunity to increase their knowledge of dementia, improve lifestyle risk factors and engage with researchers. The program, Brain Health PRO (BHPro), offers interactive digital educational modules to empower older adults to improve their physical and mental health and modify their risk factors for dementia.
The bilingual program focuses on seven different modifiable dementia risk domains: exercise, nutrition, sleep, psychological and social health, cognitive engagement, heart health, and vision and hearing. For each, the program includes 10-minute educational videos, as well as interactive activities for users to complete. Participants will also be sent portable EEG headsets to measure their brain activity during sleep, and accelerometers to track their physical activity. With the rise of dementia anticipated to reach nearly 1 million Canadians over the next 12 years, dementia prevention is becoming an increasingly urgent national health priority.
“The launch of BHPro is part of a significant research effort to find concrete means of preventing dementia, with the ultimate goal of having tremendous benefits for the aging experience,” says Dr. Howard Chertkow, Scientific Director of CCNA and Director of the Kimel Family Centre for Brain Health and Wellness at Baycrest.
“Alzheimer Society of Canada (ASC) is proud to support the launch of the BHPro through the CAN-THUMBS UP program,” says Dr. Saskia Sivananthan, ASC’s Chief Research & KTE Officer.
BHPro is funded by the Canadian Institutes of Health Research and ASC, and was created through the Canadian Therapeutic Platform Trial for Multidomain Interventions to Prevent Dementia (CAN-THUMBS UP) program, which is part of CCNA. The study will support 350 older adults across Canada who have at least one risk factor for dementia, with the goal of seeing participants’ dementia risk reduced throughout the year-long study. (klonopin) Please note, that there is limited space for research participants.
